iRadimed
IRMD
166 hedge funds and large institutions have $383M invested in iRadimed in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 11 closing their positions.
218% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 11
68% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 40
15% more funds holding
Funds holding: 144 → 166 (+22)
13% more capital invested
Capital invested by funds: $340M → $383M (+$43M)
1.54% more ownership
Funds ownership: 53.47% → 55.01% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
85% less call options, than puts
Call options by funds: $33K | Put options by funds: $225K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$2.8M |
| 2 |
Bank of New York Mellon
New York
|
+$2.55M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.78M |
| 4 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$1.71M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.9M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$1.44M |
| 3 |
Renaissance Technologies
New York
|
-$1.39M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.22M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$1.18M |
IRMD Hedge Fund Activity: Q4 2024 in Review
166 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2024, worth a combined $383M — up 13% from $340M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new IRMD positions and 11 closed out — a net gain of 24 holders — while 67 added to existing stakes and 40 trimmed.
The largest buyer was Copeland Capital Management, adding an estimated $2.8M. The largest seller was Millennium Management, cutting an estimated $1.9M.
- 166 institutional investors held iRadimed (IRMD) as of Q4 2024, up from 144 in Q3 2024.
- Funds reported $383M of iRadimed stock for Q4 2024, up 13% quarter-over-quarter.
- 35 funds opened new iRadimed positions in Q4 2024 and 11 closed out, a net change of +24 holders.
- The largest iRadimed buyer in Q4 2024 was Copeland Capital Management, an estimated $2.8M added.
- The largest iRadimed seller in Q4 2024 was Millennium Management, an estimated $1.9M sold.
Based on aggregated 13F filings for Q4 2024.